Cleveland-Cliffs Inc. (CLF)

Elevation Oncology Stock Forecast

Stock Price Forecast

The 9 analysts that cover Elevation Oncology stock have a consensus rating of "Buy" and an average price target of $10.52, which forecasts a 8.34% increase in the stock price over the next year. The lowest target is $3.91 and the highest is $17.

Price Target: $10.52 (+8.34%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.91	$10.52	$11	$17
Change	-59.73%	+8.34%	+13.29%	+75.08%

Analyst Ratings

The average analyst rating for Elevation Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	5	5	6	4	4	3
Buy	0	0	0	0	0	1
Hold	4	4	4	5	4	4
Sell	2	1	0	0	0	0
Strong Sell	0	0	0	1	1	1
Total	11	10	10	10	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Peterson JP Morgan	JP Morgan	Hold Maintains $7.5 → $10	Hold	Maintains	$7.5 → $10	+2.99%	Jul 24, 2025
Carlos De Alba Morgan Stanley	Morgan Stanley	Hold Maintains $8 → $11	Hold	Maintains	$8 → $11	+8.14%	Jul 22, 2025
Philip Gibbs Keybanc	Keybanc	Hold → Buy Upgrades $14	Hold → Buy	Upgrades	$14	+44.18%	Jul 22, 2025
Alexander Hacking Citigroup	Citigroup	Hold Maintains $7.5 → $11	Hold	Maintains	$7.5 → $11	+13.29%	Jul 21, 2025
Bill Peterson JP Morgan	JP Morgan	Hold Initiates $7.5	Hold	Initiates	$7.5	-22.76%	Jul 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

19.68B

Increased by 2.57%

from 19.19B

Revenue Next Year

20.75B

Increased by 5.42%

from 19.68B

EPS This Year

-2.11

from -1.57

EPS Next Year

-0.01

from -2.11

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.35B	20.44B	22.99B	22.00B	19.19B	19.68B	20.75B	21.57B
Revenue Growth	169.05%	281.84%	12.45%	-4.32%	-12.78%	2.57%	5.42%	3.98%
EPS	-0.32	5.35	2.56	0.78	-1.57	-2.11	-0.01	0.09
EPS Growth	-	-	-52.27%	-69.40%	-	-	-	-
Forward PE	-	-	-	-	-	-	-	114.00
No. Analysts	-	-	-	-	-	14	14	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	22.0B	23.3B	24.4B
Avg	19.7B	20.7B	21.6B
Low	18.2B	17.8B	17.3B

Revenue Growth

Revenue Growth	2025	2026	2027
High	14.6%	18.5%	17.7%
Avg	2.6%	5.4%	4.0%
Low	-5.0%	-9.5%	-16.4%

EPS Forecast

EPS	2025	2026	2027
High	-0.89	1.65	1.00
Avg	-2.11	-0.01	0.09
Low	-3.55	-2.35	-2.98

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.